Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 85 articles:
HTML format



Single Articles


    September 2022
  1. VILLABONA-ARENAS CJ, Hue S, Baxter JAC, Hall M, et al
    Using phylogenetics to infer HIV-1 transmission direction between known transmission pairs.
    Proc Natl Acad Sci U S A. 2022;119:e2210604119.
    PubMed     Abstract available


  2. LUTZ EA, Agarwal Y, Momin N, Cowles SC, et al
    Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies.
    Proc Natl Acad Sci U S A. 2022;119:e2205983119.
    PubMed     Abstract available


    August 2022
  3. VELU V, Titanji K, Ahmed H, Shetty RD, et al
    PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques.
    Proc Natl Acad Sci U S A. 2022;119:e2202148119.
    PubMed     Abstract available


  4. LY PT, Xu S, Wirawan M, Luo D, et al
    ZAP isoforms regulate unfolded protein response and epithelial- mesenchymal transition.
    Proc Natl Acad Sci U S A. 2022;119:e2121453119.
    PubMed     Abstract available


    July 2022
  5. SINGH AK, De Wijngaert B, Bijnens M, Uyttersprot K, et al
    Cryo-EM structures of wild-type and E138K/M184I mutant HIV-1 RT/DNA complexed with inhibitors doravirine and rilpivirine.
    Proc Natl Acad Sci U S A. 2022;119:e2203660119.
    PubMed     Abstract available


  6. YUAN M, Zhu X, He WT, Zhou P, et al
    A broad and potent neutralization epitope in SARS-related coronaviruses.
    Proc Natl Acad Sci U S A. 2022;119:e2205784119.
    PubMed     Abstract available


  7. WALKER-SPERLING V, Digitale JC, Viard M, Martin MP, et al
    Genetic variation that determines TAPBP expression levels associates with the course of malaria in an HLA allotype-dependent manner.
    Proc Natl Acad Sci U S A. 2022;119:e2205498119.
    PubMed     Abstract available


  8. CADA AK, Pavlin MR, Castillo JP, Tong AB, et al
    Friction-driven membrane scission by the human ESCRT-III proteins CHMP1B and IST1.
    Proc Natl Acad Sci U S A. 2022;119:e2204536119.
    PubMed     Abstract available


  9. BALDWIN ET, Gotte M, Tchesnokov EP, Arnold E, et al
    Human endogenous retrovirus-K (HERV-K) reverse transcriptase (RT) structure and biochemistry reveals remarkable similarities to HIV-1 RT and opportunities for HERV-K-specific inhibition.
    Proc Natl Acad Sci U S A. 2022;119:e2200260119.
    PubMed     Abstract available


  10. CACCURI F, Messali S, Zani A, Campisi G, et al
    HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide.
    Proc Natl Acad Sci U S A. 2022;119:e2122050119.
    PubMed     Abstract available


    June 2022
  11. SAMAL AB, Green TJ, Saad JS
    Atomic view of the HIV-1 matrix lattice; implications on virus assembly and envelope incorporation.
    Proc Natl Acad Sci U S A. 2022;119:e2200794119.
    PubMed     Abstract available


    May 2022
  12. HORVATH S, Lu AT, Haghani A, Zoller JA, et al
    DNA methylation clocks for dogs and humans.
    Proc Natl Acad Sci U S A. 2022;119:e2120887119.
    PubMed     Abstract available


  13. MANRY J, Bastard P, Gervais A, Le Voyer T, et al
    The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
    Proc Natl Acad Sci U S A. 2022;119:e2200413119.
    PubMed     Abstract available


  14. TIAN JB, Yang J, Joslin WC, Flockerzi V, et al
    TRPC4 and GIRK channels underlie neuronal coding of firing patterns that reflect Gq/11-Gi/o coincidence signals of variable strengths.
    Proc Natl Acad Sci U S A. 2022;119:e2120870119.
    PubMed     Abstract available


  15. TAURA M, Frank JA, Takahashi T, Kong Y, et al
    APOBEC3A regulates transcription from interferon-stimulated response elements.
    Proc Natl Acad Sci U S A. 2022;119:e2011665119.
    PubMed     Abstract available


  16. OLABODE AS, Ng GT, Wade KE, Salnikov M, et al
    Revisiting the recombinant history of HIV-1 group M with dynamic network community detection.
    Proc Natl Acad Sci U S A. 2022;119:e2108815119.
    PubMed     Abstract available


  17. KAVAKLI KC, Rotondi V
    US foreign aid restrictions and maternal and children's health: Evidence from the "Mexico City Policy".
    Proc Natl Acad Sci U S A. 2022;119:e2123177119.
    PubMed     Abstract available


    April 2022

  18. Correction for Lu et al., Screening for gene expression fluctuations reveals latency-promoting agents of HIV.
    Proc Natl Acad Sci U S A. 2022;119:e2203398119.
    PubMed    


  19. SENGUPTA S, Board NL, Wu F, Moskovljevic M, et al
    TCR-mimic bispecific antibodies to target the HIV-1 reservoir.
    Proc Natl Acad Sci U S A. 2022;119:e2123406119.
    PubMed     Abstract available


    March 2022
  20. YU A, Lee EMY, Briggs JAG, Ganser-Pornillos BK, et al
    Strain and rupture of HIV-1 capsids during uncoating.
    Proc Natl Acad Sci U S A. 2022;119:e2117781119.
    PubMed     Abstract available


  21. ZEBERG H
    The major genetic risk factor for severe COVID-19 is associated with protection against HIV.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


    February 2022
  22. LIU H, Zheng ZM
    Linking a nuclear lncRNA to cytoplasmic lysosome integrity and cell death.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed    


  23. SWAN DA, Rolland M, Herbeck JT, Schiffer JT, et al
    Evolution during primary HIV infection does not require adaptive immune selection.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  24. WHITE JA, Simonetti FR, Beg S, McMyn NF, et al
    Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  25. NIGHTINGALE K, Potts M, Hunter LM, Fielding CA, et al
    Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


    January 2022
  26. YANG B, Jia Y, Meng Y, Xue Y, et al
    SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  27. CHO A, Gaebler C, Olveira T, Ramos V, et al
    Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  28. GEIS FK, Sabo Y, Chen X, Li Y, et al
    CHAF1A/B mediate silencing of unintegrated HIV-1 DNAs early in infection.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  29. RUJAS E, Cui H, Burnie J, Aschner CB, et al
    Engineering pan-HIV-1 neutralization potency through multispecific antibody avidity.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  30. WANG S, Zhao L, Zhang X, Zhang J, et al
    Neuropilin-1, a myeloid cell-specific protein, is an inhibitor of HIV-1 infectivity.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  31. SINGH G, Seufzer B, Song Z, Zucko D, et al
    HIV-1 hypermethylated guanosine cap licenses specialized translation unaffected by mTOR.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available



  32. Correction for Shanmugapriya et al., Dynactin 1 negatively regulates HIV-1 infection by sequestering the host cofactor CLIP170.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed    


    December 2021
  33. NIKOLAITCHIK OA, Liu S, Kitzrow JP, Liu Y, et al
    Selective packaging of HIV-1 RNA genome is guided by the stability of 5' untranslated region polyA stem.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    November 2021
  34. WICHE SALINAS TR, Zhang Y, Sarnello D, Zhyvoloup A, et al
    Th17 cell master transcription factor RORC2 regulates HIV-1 gene expression and viral outgrowth.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  35. SHEVCHENKO AK, Zhernakova DV, Malov SV, Komissarov A, et al
    Genome-wide association study reveals genetic variants associated with HIV-1C infection in a Botswana study population.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  36. PAQUIN-PROULX D, Lal KG, Phuang-Ngern Y, Creegan M, et al
    Preferential and persistent impact of acute HIV-1 infection on CD4(+) iNKT cells in colonic mucosa.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  37. LEVY R, Zhang P, Bastard P, Dorgham K, et al
    Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  38. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
    Reply to Briggs et al.: Genomic integration and expression of SARS-CoV-2 sequences can explain prolonged or recurrent viral RNA detection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


    October 2021
  39. SHANMUGAPRIYA S, Santos da Silva E, Campbell JA, Boisjoli MP, et al
    Dynactin 1 negatively regulates HIV-1 infection by sequestering the host cofactor CLIP170.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  40. RAK R, Polonsky M, Eizenberg-Magar I, Mo Y, et al
    Dynamic changes in tRNA modifications and abundance during T cell activation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  41. LEVIN JG, Rein A
    Show your cap or be packaged into HIV-1.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  42. SCHWANDT H, Currie J, Bar M, Banks J, et al
    Inequality in mortality between Black and White Americans by age, place, and cause and in comparison to Europe, 1990 to 2018.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    September 2021
  43. KING HAD, Joyce MG, Lakhal-Naouar I, Ahmed A, et al
    Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  44. DING P, Kharytonchyk S, Kuo N, Cannistraci E, et al
    5'-Cap sequestration is an essential determinant of HIV-1 genome packaging.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    August 2021
  45. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
    Response to Parry et al.: Strong evidence for genomic integration of SARS-CoV-2 sequences and expression in patient tissues.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    



  46. Correction for Madan et al., Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  47. HARDCASTLE M
    QnAs with Joel N. Blankson.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


    July 2021
  48. MEIJERS M, Vanshylla K, Gruell H, Klein F, et al
    Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  49. YIN Y, Quinlan BD, Ou T, Guo Y, et al
    In vitro affinity maturation of broader and more-potent variants of the HIV-1-neutralizing antibody CAP256-VRC26.25.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  50. AKULLIAN A, Vandormael A, Miller JC, Bershteyn A, et al
    Large age shifts in HIV-1 incidence patterns in KwaZulu-Natal, South Africa.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  51. IMAI M, Halfmann PJ, Yamayoshi S, Iwatsuki-Horimoto K, et al
    Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    June 2021
  52. CHRETIEN AS, Devillier R, Granjeaud S, Cordier C, et al
    High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    May 2021
  53. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
    Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  54. HAIDER T, Snetkov X, Jolly C
    HIV envelope tail truncation confers resistance to SERINC5 restriction.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  55. MORVAN MG, Teque F, Ye L, Moreno ME, et al
    Genetically edited CD34(+) cells derived from human iPS cells in vivo but not in vitro engraft and differentiate into HIV-resistant cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    April 2021
  56. MA G, Yasunaga JI, Shimura K, Takemoto K, et al
    Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  57. YEH YJ, Ho YC
    Shock-and-kill versus block-and-lock: Targeting the fluctuating and heterogeneous HIV-1 gene expression.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  58. CUI W, Braun E, Wang W, Tang J, et al
    Structural basis for GTP-induced dimerization and antiviral function of guanylate-binding proteins.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  59. RUAN Q, Macdonald PJ, Swift KM, Tetin SY, et al
    Direct single-molecule imaging for diagnostic and blood screening assays.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  60. LOPEZ ANGEL CJ, Pham EA, Du H, Vallania F, et al
    Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    March 2021
  61. RUSSELL RM, Bibollet-Ruche F, Liu W, Sherrill-Mix S, et al
    CD4 receptor diversity represents an ancient protection mechanism against primate lentiviruses.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  62. PEDRO KD, Agosto LM, Sewell JA, Eberenz KA, et al
    A functional screen identifies transcriptional networks that regulate HIV-1 and HIV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  63. LU Y, Bohn-Wippert K, Pazerunas PJ, Moy JM, et al
    Screening for gene expression fluctuations reveals latency-promoting agents of HIV.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  64. LI C, Burdick RC, Nagashima K, Hu WS, et al
    HIV-1 cores retain their integrity until minutes before uncoating in the nucleus.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  65. MADAN B, Zhang B, Xu K, Chao CW, et al
    Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  66. CONTI S, Kaczorowski KJ, Song G, Porter K, et al
    Design of immunogens to elicit broadly neutralizing antibodies against HIV targeting the CD4 binding site.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    February 2021
  67. BURTON DR
    A new lease on life for an HIV-neutralizing antibody class and vaccine target.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  68. MURAKOWSKI DK, Barton JP, Peter L, Chandrashekar A, et al
    Adenovirus-vectored vaccine containing multidimensionally conserved parts of the HIV proteome is immunogenic in rhesus macaques.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    January 2021
  69. TAN A, Pak AJ, Morado DR, Voth GA, et al
    Immature HIV-1 assembles from Gag dimers leaving partial hexamers at lattice edges as potential substrates for proteolytic maturation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  70. LIU H, Xu J, Yang Y, Wang X, et al
    Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  71. HAYN M, Blotz A, Rodriguez A, Vidal S, et al
    Natural cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  72. MONTEFIORI DC, Filsinger Interrante MV, Bell BN, Rubio AA, et al
    The high-affinity immunoglobulin receptor FcgammaRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  73. CACCURI F, D'Ursi P, Uggeri M, Bugatti A, et al
    Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  74. FERNANDEZ J, Hassen-Khodja C, Georget V, Rose T, et al
    Measuring the subcellular compartmentalization of viral infections by protein complementation assay.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    December 2020
  75. YOON JK, Holloway JR, Wells DW, Kaku M, et al
    HIV proviral DNA integration can drive T cell growth ex vivo.
    Proc Natl Acad Sci U S A. 2020 Dec 14. pii: 2013194117.
    PubMed     Abstract available


  76. GOES LR, Sajani A, Sivro A, Olowojesiku R, et al
    The V2 loop of HIV gp120 delivers costimulatory signals to CD4(+) T cells through Integrin alpha4beta7 and promotes cellular activation and infection.
    Proc Natl Acad Sci U S A. 2020 Dec 7. pii: 2011501117.
    PubMed     Abstract available


    November 2020
  77. BERTAGNOLLI LN, Varriale J, Sweet S, Brockhurst J, et al
    Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1.
    Proc Natl Acad Sci U S A. 2020 Nov 25. pii: 2020617117.
    PubMed     Abstract available


  78. DI PUCCHIO T, Sekaly RP
    HLA polymorphism and tapasin independence influence outcomes of HIV and dengue virus infection.
    Proc Natl Acad Sci U S A. 2020 Nov 25. pii: 2020109117.
    PubMed    


  79. DATTA R, Roy Chowdhury R, Manjunath K, Hanna LE, et al
    A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing.
    Proc Natl Acad Sci U S A. 2020 Nov 9. pii: 2010256117.
    PubMed     Abstract available


  80. CARTER SD, Mamede JI, Hope TJ, Jensen GJ, et al
    Correlated cryogenic fluorescence microscopy and electron cryo-tomography shows that exogenous TRIM5alpha can form hexagonal lattices or autophagy aggregates in vivo.
    Proc Natl Acad Sci U S A. 2020 Nov 5. pii: 1920323117.
    PubMed     Abstract available


    October 2020
  81. BASHIROVA AA, Viard M, Naranbhai V, Grifoni A, et al
    HLA tapasin independence: broader peptide repertoire and HIV control.
    Proc Natl Acad Sci U S A. 2020 Oct 23. pii: 2013554117.
    PubMed     Abstract available


  82. BERNDSEN ZT, Chakraborty S, Wang X, Cottrell CA, et al
    Visualization of the HIV-1 Env glycan shield across scales.
    Proc Natl Acad Sci U S A. 2020 Oct 22. pii: 2000260117.
    PubMed     Abstract available


    September 2020
  83. FUJIMOTO M, Ebine K, Nishimura K, Tsutsumi N, et al
    Longin R-SNARE is retrieved from the plasma membrane by ANTH domain-containing proteins in Arabidopsis.
    Proc Natl Acad Sci U S A. 2020 Sep 23. pii: 2011152117.
    PubMed     Abstract available


  84. RAUSCH JW, Capoferri AA, Katusiime MG, Patro SC, et al
    Low genetic diversity may be an Achilles heel of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020 Sep 21. pii: 2017726117.
    PubMed    


    August 2020
  85. DOCTROW B
    QnAs with Hashim Al-Hashimi.
    Proc Natl Acad Sci U S A. 2020;117:18146-18147.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: